Publication | Closed Access
A New Highly Thyrotropin Receptor-Selective Small-Molecule Antagonist with Potential for the Treatment of Graves' Orbitopathy
83
Citations
45
References
2018
Year
In summary, a novel highly selective inhibitor for the TSHR is presented, which has promising potential for further development for the treatment of GO.
| Year | Citations | |
|---|---|---|
Page 1
Page 1